Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Clinical trial NCT05417594 · RECRUITING
Trial details
- NCT number
- NCT05417594
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-24
- Primary completion
- 2028-02-07
- Enrollment
- 695
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.